Semler Scientific以1000萬美元的價格收購了111個比特幣，將其持股量達到3,303 BTC

此次收購將Semler Scientific的持股量帶到了3,303個比特幣。

Medical technology company Semler Scientific announced the acquisition of 111 more bitcoins (BTC) for $10 million between February 14 and April 24.

醫療技術公司Semler Scientific宣佈在2月14日至4月24日之間以1000萬美元的價格收購了111個比特幣（BTC）。

Semler Scientific Announces New BTC Holdings

Semler Scientific宣布了新的BTC控股

Semler Scientific (Nasdaq: SMLR) disclosed that it bought the coins for an average price of $90,124 per bitcoin using net proceeds from its at-the-market (ATM) offering program and available cash.

Semler Scientific（NASDAQ：SMLR）透露，它使用其在市場（ATM）發行計劃和可用現金的淨收益購買了每比特幣90,124美元的硬幣。

The additional bitcoins brought Semler Scientific’s holdings to 3,303 bitcoins purchased for a total of $290.4 million at an average price of $87,929 per bitcoin. The market value of Semler Scientific’s BTC holdings on April 24 at 4 p.m. EDT was $309.1 million.

額外的比特幣將Semler Scientific的股份帶到了3,303個比特幣，總計2.904億美元，平均價格為每比特幣87,929美元。 EDT 4月24日下午4點，Semler Scientific的BTC持有的市場價值為3.091億美元。

The latest BTC holdings update comes a little over a week after Semler Scientific filed for a $500 million mixed-securities offering to fund further bitcoin acquisitions.

最新的BTC控股更新是在Semler Scientific申請了5億美元的混合安全產品以資助更多比特幣收購後的一周多了一周的時間。

The filing permits Semler Scientific to sell debt securities, common stock or units and use the proceeds primarily to buy more BTC.

該文件允許Semler Scientific出售債務證券，普通股或單位，並主要使用收益購買更多BTC。

To support its bitcoin purchases, Semler Scientific had been utilizing a new Controlled Equity Offering Sales Agreement.

為了支持其比特幣購買，Semler Scientific一直使用新的受控權益提供銷售協議。

The medical technology company disclosed that it had initially entered into an agreement with Cantor Fitzgerald, commencing in January 2025, for the sale of shares of its common stock to generate proceeds to fund bitcoin acquisitions.

這家醫療技術公司透露，它最初與坎托·菲茨杰拉德（Cantor Fitzgerald）達成了一項協議，該協議於2025年1月開始，以出售其普通股以產生收益以資助比特幣收購。

Through this agreement, Semler Scientific issued and sold 2,438,274 shares for net proceeds of approximately $126 million. Following the effectiveness of a new ATM equity offering program on April 22, 2025, Semler Scientific ceased selling shares under the initial agreement with Cantor Fitzgerald.

通過這項協議，Semler Scientific發行並出售了2,438,274股，淨收益約為1.26億美元。在2025年4月22日新的ATM股權產品計劃的有效性之後，Semler Scientific停止根據與Cantor Fitzgerald的初步協議出售股票。

However, the company announced that it had closed a new ATM offering with Barclays Capital, Cantor Fitzgerald, Canaccord Genuity LLC, Point72 Ventures and Ridge Capital Partners on April 23, 2025. This new offering allows Semler Scientific to issue and sell up to $500 million in common stock.

但是，該公司宣布已於2025年4月23日與巴克萊資本，Cantor Fitzgerald，Canaccord Genuity LLC，Point72 Ventures和Ridge Capital Partners關閉了新的ATM產品。這項新產品允許Semler Scientific發行並出售高達5億美元的普通股。

As of April 24, Semler Scientific had sold 57,100 shares under this new offering, generating approximately $2 million in net proceeds.

截至4月24日，Semler Scientific在此新產品下售出了57,100股，產生了約200萬美元的淨收益。

According to the statement, Semler Scientific reported a 23.5% year-to-date BTC yield through April 24, 2025. The company uses BTC yield as a key performance indicator (KPI) to evaluate its bitcoin acquisition strategy and assess its impact on stockholders.

根據聲明，Semler Scientific報告到2025年4月24日，年初至今的BTC收益率為23.5％。該公司使用BTC收益率作為關鍵績效指標（KPI）來評估其比特幣獲取策略，並評估其對股東的影響。

Semler Scientific believes this KPI is useful to investors seeking to understand its decision to fund the purchase of BTC by issuing additional shares of its common stock or instruments convertible to common stock.

Semler Scientific認為，該KPI對尋求了解其決定購買BTC的決定的投資者很有用，該決定通過發行其普通股或可轉換為普通股的工具的其他股份來購買BTC。